Time to read
1 minute
Read so far

Duration of obesity associated with increased risk of higher risk of cardiometabolic disease

Tue, 12/08/2020 - 13:53
Posted in:

A greater obesity duration is associated with worse values for all cardiometabolic disease factors, according to a study by Dr Tom Norris of Loughborough University, UK, and colleagues. The study, 'Duration of obesity exposure between ages 10 and 40 years and its relationship with cardiometabolic disease risk factors: A cohort study', was published in PLoS Medicine.

People with obesity do not all share the same risk for the development of cardiometabolic disease risk factors. The duration a person has spent with obesity over their lifetime has been hypothesised to affect this variation. In this study, researchers used data from three British birth cohort studies that collected information on body mass index from age 10 to 40 as well as cardiometabolic disease risk factors - blood pressure, cholesterol and glycated haemoglobin measurements - in 20,746 participants (49.1% male and 97.2% white British).

More years of obesity was associated with worse values for all measured cardiometabolic risk factors. The association was particularly strong for glycated haemoglobin those with less than five years of obesity had a 5% higher HbA1c (95%Confidence Interval 4-6) compared to people with no years of obesity, while those with 20 to 30 years of obesity had a 20% higher HbA1c (95%CI 17-23) compared to people with no obesity.

Importantly, this increased risk persisted when adjustment was made for a robust measure of life course obesity severity. Other measures of cardiometabolic disease risk (systolic and diastolic blood pressure, high density-lipoprotein cholesterol) were also associated with obesity duration, though these were largely attenuated when adjusting for obesity severity.

“Given that the obesity epidemic is characterised by a much earlier onset of obesity and consequently a greater lifetime exposure, our findings suggest that health policy recommendations aimed at preventing early obesity onset, and therefore reducing lifetime exposure, may help reduce the risk of diabetes, independently of obesity severity,” the authors concluded. “However, to test the robustness of our observed associations, triangulation of evidence from different epidemiological approaches (e.g., mendelian randomization and negative control studies) should be obtained.”

To access this paper, please click here